Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
Organoruthenium complexes with benzo-fused pyrithiones overcome platinum resistance in ovarian cancer cells
ID
Kladnik, Jerneja
(
Author
),
ID
Coverdale, James P. C.
(
Author
),
ID
Kljun, Jakob
(
Author
),
ID
Burmeister, Hilke
(
Author
),
ID
Lippman, Petra
(
Author
),
ID
Ellis, Francesca G.
(
Author
),
ID
Jones, Alan M.
(
Author
),
ID
Ott, Ingo
(
Author
),
ID
Romero-Canelón, Isolda
(
Author
),
ID
Turel, Iztok
(
Author
)
PDF - Presentation file,
Download
(3,10 MB)
MD5: C069A57EB65F60B7C01CC82570AAF965
URL - Source URL, Visit
https://www.mdpi.com/2072-6694/13/10/2493
Image galllery
Abstract
Drug resistance to existing anticancer agents is a growing clinical concern, with many first line treatments showing poor efficacy in treatment plans of some cancers. Resistance to platinum agents, such as cisplatin, is particularly prevalent in the treatment of ovarian cancer, one of the most common cancers amongst women in the developing world. Therefore, there is an urgent need to develop next generation of anticancer agents which can overcome resistance to existing therapies. We report a new series of organoruthenium(II) complexes bearing structurally modified pyrithione ligands with extended aromatic scaffold, which overcome platinum and adriamycin resistance in human ovarian cancer cells. The mechanism of action of such complexes appears to be unique from that of cisplatin, involving G$_1$ cell cycle arrest without generation of cellular ROS, as is typically associated with similar ruthenium complexes. The complexes inhibit the enzyme thioredoxin reductase (TrxR) in a model system and reduce cell motility towards wound healing. Importantly, this work highlights further development in our understanding of the multi-targeting mechanism of action exhibited by transition metal complexes.
Language:
English
Keywords:
ruthenium
,
pyrithione
,
resistance to chemotherapy
,
cancer
,
ovarian
,
thioredoxin
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
FKKT - Faculty of Chemistry and Chemical Technology
Publication status:
Published
Publication version:
Version of Record
Year:
2021
Number of pages:
21 str.
Numbering:
Vol. 13, iss. 10, art. 2493
PID:
20.500.12556/RUL-135447
UDC:
546.96:547.8:618.11-006
ISSN on article:
2072-6694
DOI:
10.3390/cancers13102493
COBISS.SI-ID:
64129539
Publication date in RUL:
15.03.2022
Views:
960
Downloads:
130
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Cancers
Shortened title:
Cancers
Publisher:
MDPI
ISSN:
2072-6694
COBISS.SI-ID:
517914137
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:
20.05.2021
Secondary language
Language:
Slovenian
Keywords:
rutenij
,
organorutenijevi kompleksi
,
piritioni
,
rak jajčnikov
Projects
Funder:
ARRS - Slovenian Research Agency
Funding programme:
Young researchers
Funder:
ARRS - Slovenian Research Agency
Project number:
P1-0175
Name:
Napredna anorganska kemija
Funder:
ARRS - Slovenian Research Agency
Project number:
BI-DE/17-19-3
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back